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Abstract 49 
The restrictive properties of TRIM5α from small ruminant species have not been explored. 50 
Here, we identify highly similar TRIM5α sequences in sheep and goats. Cells transduced 51 
with ovine TRIM5α effectively restricted the lentivirus Visna/Maedi DNA synthesis. 52 
Proteasome inhibition in cells transduced with ovine TRIM5α restored restricted viral DNA 53 
synthesis suggesting a conserved mechanism of restriction. Identification of TRIM5α-active 54 
molecular species may open new prophylactic strategies against lentiviral infections.  55 
 56 
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Small ruminant lentiviruses (SRLV), including Visna/Maedi virus (VMV) and caprine 72 
encephalitis virus (CAEV) are widespread in sheep and goats, causing a slow progressive 73 
disease. Since neither treatment nor efficient vaccines are available, infection is commonly 74 
controlled by early diagnosis and culling (23). Recently, the study of host cell restriction 75 
factors interfering with the retroviral life cycle such as the tripartite motif-containing 5 76 
(TRIM5) protein has gained interest (10, 37). TRIM5 family members bear a RING-B-box-77 
coiled-coil structure consisting of a N-terminal RING domain (with E3 ubiquitin ligase 78 
activity); a B-box domain and a coiled-coil domain (19). The TRIM5α isoform, which is 79 
active against retroviruses, contains a C-terminal PRYSPRY domain that binds retroviral 80 
capsid, CA (12, 20, 35). This interaction, involving amino acid 332 of TRIM5α in humans 81 
(15) and 334 in monkeys, may explain the high relative rates of non-synonymous changes 82 
of the primate TRIM5α gene (13). TRIM5α has been described in primates and several 83 
mammals (3, 6, 30, 33, 41), but not in sheep or goats, both of which are infected by SRLV, 84 
their own lentivirus. This study aimed to identify and characterise the ovine and caprine 85 
TRIM5α and explore the possible restrictive role of ovine TRIM5α on VMV infection.  86 
First, we cloned and sequenced ovine and caprine TRIM5α cDNA sequences. For this, total 87 
RNA from ovine skin fibroblasts (SF), bronchoalveolar lavage (BAL) or lung tissue 88 
obtained from domestic sheep of the Assaf (n=3), Churra (n=2) and Rasa Aragonesa (n=4) 89 
breeds was purified using TRIzol (Invitrogen) passed through RNeasy mini kit columns 90 
(Qiagen), before being reverse transcribed with SuperScript II (Invitrogen) using oligo-dT 91 
primer, according to the manufacturer’s instructions. To clone the caprine counterpart, 92 
cDNA from peripheral blood mononuclear cells (PBMC) from goats of the Roccaverano 93 
(n=1) and Murciano-Granadina (n=2) breeds was used. These cDNA were employed as 94 
PCR template using Phusion high-fidelity DNA polymerase (Finnzymes) with the forward 95 
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primer TrimEXNFw 5’-TGCACCTCGAGATGGCTTCAGGAATCCTG-3’ (XhoI site 96 
underlined) and the reverse primer PJ2 5’-GATCCGGGCCCTCAACAGCTTGGTGAGC-97 
3’ (ApaI site underlined) following standard thermal profiles. Amplified products were 98 
cloned into the TOPO Blunt vector (Invitrogen) as a shuttle/sequencing vector yielding a 99 
total of 12 ovine and 5 caprine independent sequences. Four ovine sequences were obtained 100 
at least twice and were aligned with previously described TRIM5α sequences (ClustalX and 101 
PHYLIP: Phylogeny Inference Package version 3.5c), revealing a conserved structure 102 
across species. Analysis of 6 clones from SF of one Rasa Aragonesa sheep revealed the 103 
presence of only two TRIM5α amino acid sequences (named Ov1 and Ov2) suggesting that 104 
these sequences are encoded by a single heterozygous gene. The sequences differed only at 105 
a single residue (339) of the PRYSPRY-domain V1 region. Greater levels of amino acid 106 
diversity were found in additional sheep and goat sequences (Fig. 1). To examine sequence 107 
diversity phylogenetic trees were produced by the Neighbour Joining method with 108 
Kimura’s correction using 1000 bootstrap confidence limits. Results with over 950 109 
bootstraps were considered highly likely. As expected, ovine and caprine sequences were 110 
closely related, followed by bovine sequences (Table 1) forming a non-primate TRIM5α 111 
cluster (Fig. 2). Comparison of these sequences revealed greater variation between caprine 112 
and ovine TRIM5α than between ovine sequences (Table 1; Fig. 1a), with the PRYSPRY 113 
being the most variable domain. Such variation was higher than expected given that sheep 114 
and goats diverged 6 million years ago (16), whereas human and chimpanzees, which 115 
encode more highly related TRIM5α sequences, diverged 7 million years ago (5). The close 116 
relatedness between sheep and goats is consistent with the ability of sheep (VMV) and goat 117 
(CAEV) lentiviruses to infect both ruminant species (8, 32). The high variability of both, 118 
PRYSPRY (6, 34); this work) and CA of SRLV (7, 26) may account for the evolution of 119 
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both, virus and host, involving TRIM5α and CA interactions, as described in primate 120 
lentiviruses (11, 28, 34, 38). Natural selection in ovine and caprine sequences was 121 
determined by estimating ω (ratio of the rate of non-synonymous substitutions, dN, to 122 
synonymous substitutions, dS), using three methods, Single-Likelihood Ancestor Counting 123 
(SLAC), fixed effects likelihood (FEL) and random effects likelihood (REL) implemented 124 
in the Datamonkey webserver (21). The existence of strong positive selection observed 125 
when comparing other species (6, 17, 29, 34) was not observed in sheep vs. goat 126 
comparisons (p≥0.064), consistent with viral transmission between these species. 127 
Additional RNA species (6 from a total of 3 sheep) were identified that had a stop codon at 128 
residue 347 compared to the full ovine protein TRIM5α (OvT5α), resulting in a reduced 129 
number of exons and elongated non-coding sequences at the 3’end, a structure similar to 130 
that of human TRIM5γ (2); (Fig. 1b). No splicing donor/acceptor consensus sequences 131 
were found in the shortened TRIM5α sequences under study, suggesting that truncated 132 
proteins are indeed splice variants of TRIM5 and that splicing of these forms is conserved 133 
between primates and ruminants. Numerous isoforms that are shorter than the antiviral 134 
TRIM5α exist in humans (2) and macaques (4). Some of these lack the PRYSPRY domain, 135 
and are therefore unrestrictive. Like human TRIM5γ (36), the short ovine isoform is likely 136 
to act as a dominant negative through lack of a viral binding PRYSPRY domain (2).  137 
To characterize restriction by OvT5, sequences Ov1, Ov2 (both from SF of a seronegative 138 
Rasa Aragonesa sheep from a seropositive flock) and Ov4 (obtained from BAL cells of a 139 
Rasa Aragonesa seropositive sheep affected with pneumonia), were cloned into the 140 
gammaretroviral expression vector pCNCR-HA, using XhoI/ApaI restriction sites. The 141 
vector contains the LTR of Moloney Murine Leukemia virus (MLV), driving expression of 142 
an N-terminal hemaglutinin (HA) tagged OvT5α protein and the gene for the red 143 
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fluorescent protein (RFP). The resulting vector (pCTCR-HAOvT5) was packaged into 144 
vesicular stomatitis virus G envelope protein (VSV-G)-pseudotyped MLV cores by co-145 
transfection of 293T cells as described (3). Culture supernatants containing MLV virions 146 
encoding OvT5 were used to transduce the Mus dunni Tail Fibroblast (MDTF) cell line, and 147 
HA-tagged OvT5 stably expressing cells were obtained. Cells transduced with empty 148 
pCNCR-HA were used as controls. Single cell clones were isolated by limiting dilution, 149 
identified by red fluorescence microscopy, expanded and checked for expression of 150 
TRIM5α proteins by western-blot using anti-HA antibodies and quantitative RT-PCR with 151 
primers forward (qPCR3T5Fw 5’-TTCCTAGACTATGAGGCTTGCTCTGT-3’) and 152 
reverse (qPCR3T5Rv 5’-TTCTGAGGAAAGGAACATGAAGAGA-3’), designed within 153 
the PRYSPRY region. β-actin RT-PCR allowed relative quantification using described 154 
primers (24).  155 
Transduced MDTF cells expressed OvT5-HA according to WB (Fig. 3b) and RT-PCR (not 156 
shown). These OvT5-expressing clones were subjected to infection by VMV strain Ev1 157 
(27) to study restriction. Dose was determined by titrating Ev1 by inoculation of ten-fold 158 
serial dilutions onto ovine SF and visualization of the cytopathic effect by microscopy after 159 
7 days. Titres, calculated by the Reed-Muench method (22), were expressed as tissue 160 
culture infectious dose 50 (TCID50) per ml. Cells were infected at an apparent MOI of 0.2 161 
and 16 hours later MDTF total DNA purified using QIAamp DNA Mini kit (Qiagen). 162 
TaqMan quantitative PCR (qPCR) was used to measure viral DNA synthesis using a 163 
plasmid standard curve as described (9). Strain Ev1 entered and reverse transcribed in the 164 
MDTF cells. Viral DNA was detected by qPCR (mean copy numbers/100 ng DNA when 165 
infecting at 0.2 TCID50/cell being 9.9×102) and viral transcripts were produced according to 166 
RT-PCR (not shown). Thus, heterologous MDTF cells were suitable for assessing OvT5-167 
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mediated restriction, even though infection was not productive since supernatants had no 168 
RT activity up to day 20 post-inoculation (not shown). Measurement of viral DNA 169 
synthesis indicated that MDTF transduced with OvT5α were less permissive to reverse 170 
transcription than control MDTF (p <0.05). We conclude that OvT5α was able to 171 
significantly restrict VMV infectivity. TRIM5α Ov1 and Ov2 were able to restrict Ev1 172 
whereas TRIM5α Ov4, was not, despite strong expression detected by immunoblot (Fig. 3a, 173 
b). In the TRIM5α protein of humans and simians, a single amino acid substitution at 174 
position 332 or 334, abrogates TRIM5α-mediated restriction of particular viruses due to, its 175 
essential role in viral recognition (13). Specifically, any non-positively charged amino acid 176 
at that position, which belongs to a “patch” of positively selected positions, improves CA 177 
binding (15). Surprisingly, Ov1 and Ov2 had either a positively charged amino acid (K) or 178 
a negative residue (E), at this position (Fig. 1a), but both showed a similar restriction of 179 
Ev1 in MDTF cells. Due to the poor alignment of this highly variable region it is difficult to 180 
be sure that this amino acid is analogous to primate TRIM5 position 339 but it is certainly 181 
very close and putatively present on the surface of the protein in the highly variable loop 182 
that is most important for determining TRIM5α specificity. Recent studies highlight the 183 
importance of domains other than PRYSPRY (18). Significantly, Ov4 had differences in 184 
the RING and PRYSPRY domains compared with Ov1 and Ov2 and may have lost 185 
restrictive activity against VMV. Indeed, Ov4 was obtained from an infected sheep, 186 
consistent with a permissive TRIM5 genotype.  187 
 188 
In addition, we tested the restrictive role of OvT5 against VSV-G-pseudotyped HIV-2 viral 189 
vectors encoding GFP, prepared by Fugene-6 transfection of 293T cells as described (10). 190 
We infected OvT5-MDTF cells and quantified infection at 48 h by measuring GFP 191 
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expression using flow cytometry (BD FACScalibur). MDTF showed decreased levels of 192 
HIV-2 infection when expressing Ov2 (Fig. 3a), strongly suggesting a role for OvT5 in 193 
protecting sheep from HIV-2 infection.  194 
Since the proteasome has been shown to be involved in TRIM5α restriction in other species 195 
(1, 25, 40) we inhibited the proteasome and examined OvT5 mediated restriction of VMV. 196 
MDTF cells expressing TRIM5α Ov2 or empty vector were treated with pre-warmed 197 
(37ºC) proteasome inhibitor MG132 (Sigma-Aldrich) at a final concentration of 25 μM for 198 
1 h before infection with Ev1 at a MOI of 0.2. After 16 h of infection, viral DNA was 199 
quantified in duplicate by qPCR as described above and the experiment repeated three 200 
times. The results indicated that viral DNA was significantly increased (p <0.01) in 201 
proteasome-inhibited MDTF cells expressing a restrictive OvT5 compared to untreated 202 
cells. Either treated or untreated cells transduced with an empty vector showed no viral 203 
restriction, having similar levels of viral DNA (Fig. 4). The involvement of the proteasome 204 
in OvT5 restriction is in line with findings on other lentiviruses (1, 40).  205 
TRIM5α has mostly been characterised in the context of restricting heterologous viruses, 206 
but as shown here homologous virus restriction may also take place upon overexpression of 207 
TRIM5α (14, 42), This suggests that differences in TRIM5 expression levels as well as 208 
intrinsic anti-viral specificity may account for differences in permissiveness to infection 209 
between individuals (31, 42). Importantly, our study suggests functional differences 210 
between polymorphic Ovine TRIM5α variants to restrict both heterologous (HIV-2) and 211 
homologous (VMV) viruses. A better understanding of these differences could eventually 212 
be used to design SRLV control strategies such as identification and selective breeding of 213 
less permissive animals thus avoiding culling, and helping to reduce viral load and 214 
therefore disease development.  215 
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Figure legends 358 
Fig. 1. TRIM5α amino acid sequences from ruminants. A) Alignment of TRIM5α amino 359 
acid sequences from ovine (Ov1 to Ov4), caprine and bovine species. Ov1 and Ov2 were 360 
amplified from skin fibroblasts of one seronegative Rasa Aragonesa breed sheep. Ov3 and 361 
Ov4 were amplified from bronchoalveolar lavage cDNA from a seropositive Rasa 362 
Aragonesa sheep. RING, B-box-2, Coiled-coil and PRY/SPRY domains are shown and the 363 
variable segments (V1, V2 and V3) of this domain outlined. Amino acid differences 364 
between ovine sequences (Ov1 to Ov4), including those corresponding to V1 residue 339 365 
among others, are highlighted in grey. Accession numbers are: Ov1-Ov4 [GenBank: 366 
JN835300-JN835303], caprine [GenBank: JQ582845], bovine [GenBank: DQ380509]. B) 367 
Structure of the ovine TRIM5, full length isoform (top) and an alternatively spliced form 368 
(bottom).  369 
 370 
Fig. 2. Phylogenetic tree of TRIM nucleotide sequences of different species. The tree 371 
shows that all the sheep and goat TRIM5 sequences described in this work are TRIM5α 372 
orthologues. Sequences obtained here had the following GenBank accession numbers: 373 
JN835300 and JN835301: From Rasa Aragonesa skin fibroblasts. JN835302 and 374 
JN835303: From Rasa Aragonesa bronchoalveolar lavage. JN835304: From Rasa 375 
Aragonesa lung tissue. JN835305: From lung tissue of two Rasa Aragonesa and two Assaf 376 
sheep. JN835306: From lung tissue of two Assaf and one Churra sheep. JN835307: From 377 
Assaf lung tissue. JN835308: From Rasa Aragonesa lung tissue. JN835309: From Rasa 378 
Aragonesa lung tissue. JN835310: From Churra lung tissue. JN835311: From lung tissue of 379 
one Assaf and one Churra sheep. JQ582845: From peripheral blood mononuclear cells of a 380 
Roccaverano goat. JQ582846-48: From peripheral blood mononuclear cells of a Murciano-381 
15 
 
Granadina goat. JQ582849: From peripheral blood mononuclear cells of a Murciano-382 
Granadina goat. 383 
 384 
Fig. 3. Ovine TRIM5α (OvT5α) mediated restriction. (A) MDTF cells expressing 385 
OvT5α were infected with GFP-expressing HIV-2 VSV-G pseudotyped lentiviral vector or 386 
VMV strain Ev1. Data represent viral DNA copy numbers (mean values ± standard error) 387 
per 100 ng of total DNA obtained by qPCR using Ev1 specific primers/probe (9) or 388 
infectious units per ml in the case of HIV-2. Cells transduced with pCNCR-HA were used 389 
as negative controls. Three independent experiments were performed. (B) Western Blot 390 
illustrating the expression of different HA-OvT5 sequences in MDTF cells (transduced 391 
pCTCR-HAOvT5 or with the empty vector CNCR), using anti-HA-tag antibodies.   392 
 393 
Fig. 4. Effect of proteasome inhibition on VMV DNA levels in ovine OvT5α -394 
expressing cells. MDTF cells expressing restrictive OvT5α Ov2 or transduced with an 395 
empty CNCR-HA vector were treated for 1 h with proteasome inhibitor MG132 (untreated 396 
cells were used as control) before infection with VMV strain Ev1 and viral DNA was 397 
measured 16 h after infection by qPCR using Ev1 specific primers/probe. Data represent 398 
viral DNA copy numbers (mean ± standard error) per 100 ng of total DNA. Three 399 
independent experiments were performed.  400 
401 
16 
 
Table 1. Sequence Identity Matrix (percentage of similarity) on the complete encoding 402 
sequence (CDS) of the TRIM5α protein (T5) and its PRYSPRY domain, using the ovine 403 
(Ov1, Ov2, Ov3 and Ov4) and caprine amino acid sequences obtained and bovine sequence 404 
(DQ380509) available at GenBank.  405 
 406 
 407 
 408 
 409 
  Ov2   Ov3  Ov4  Caprine   Bovine 
  T5 PRYSPRY   T5 PRYSPRY  T5 PRYSPRY T5 PRYSPRY T5 PRYSPRY 
Ov1 99 99  98 98  99 99  91 89  84 76
Ov2    98 97  99 98  91 89  83 75
Ov3       99 99  92 90  84 77
Ov4          92 90  84 77
Caprine                       84 75
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Fig. 3. OvT5 mediated VMV restriction. (A) MDTF cells expressing OvT5α were infected with 
GFP-expressing HIV-2 VSV-G pseudotyped lentiviral vector or VMV strain Ev1. Data represent 
viral DNA copy numbers (mean values ± standard error) per 100 ng of total DNA obtained by 
qPCR using Ev1 specific primers/probe (9) or infectious units per ml in the case of HIV-2. Cells 
transduced with empty pCNCR-HA were used as negative controls. Three independent experiments 
were performed. (B) Western Blot illustrating the expression of different HA-OvT5 sequences in 
MDTF cells (transduced pCTCR-HAOvT5 or with the empty vector CNCR), using anti-HA-tag 
antibodies.  
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Fig. 4. Effect of proteasome inhibition on VMV DNA levels in OvT5α -expressing cells. MDTF 
cells expressing a restrictive OvT5α (for illustrative purposes only Ov2 is included) or transduced with 
an empty CNCR-HA vector were treated for 1 h with proteasome inhibitor MG132 (untreated cells 
were used as control) before infection with VMV strain Ev1 and viral DNA was measured 16 h after 
infection by qPCR using Ev1 specific primers/probe. Data represent viral DNA copy numbers 
(mean ± standard error) per 100 ng of total DNA. Three independent experiments were performed. 
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Ov2 ................................................................................ 80
Ov3 .......................................T........................................ 80
Ov4 .......................................T........................................ 80
Caprine .........................R.............T......I.....K........................... 80
Bovine .......................................TG..K..II....KR..................N....... 80
Ov1 LREVKVRPEVEQERNLCAHHGEKLQLFCEQDGKVICWLCERSQEHRGHNTFLMEEIAPQYQKMLQSCLQRLNGKKQEAEE 160
Ov2 ................................................................................ 160
Ov3 ................................................................................ 160
Ov4 ................................................................................ 160
Caprine ......S........................E........................................R....... 160
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Ov1 LEIKVREEMSTWKTQIENEMQSVQGEFTKLRQILDSEEAKELRKLKDELGIILKKLAESENDLVQEKLLVSSHISDVERH 240
Ov2 ................................................................................ 240
Ov3 ................................................................................ 240
Ov4 ................................................................................ 240
Caprine ................QT.I..............................V...V........D......NNL....... 240
Bovine .............I.....I.N...K..Q.........M...........V...E................NL....... 240
Ov1 LQGSTMELLQDVNVILKRSKTVALKEPKTFPKEQRRVFRAPDLREILRVFTELTNKQRYWVQVTLNSPKNAN-VISPHQR 319
Ov2 ........................................................................-....... 319
Ov3 ......................................................DM................-....R.. 319
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Bovine ...........A...I...E.L...K..S.....................N...DV............RS..V....D.. 320
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Ov4 ................................................................................ 399
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Ov1 YKPKNGNCGNGKNVYSRYQPTNGYWVIGLKQDSVYNAFLD----LEILALSLGVSPHRVGVFLDYEACSVLFLNVTNRGF 475
Ov2 ........................................----.................................... 475
Ov3 ........................................----....T............................H.. 475
Ov4 ........................................----....T............................H.. 475
Caprine H...................K...................----IG..T..................RT........Y.. 475
Bovine .Q...R....SQ........K.........H....K..ESSFSGP...T...S.....I.I......RT........H.. 477
Ov1 PIYKFSSCSFPQKIVPYFNPMNCDAPMTLCSPSCZ 510
Ov2 ................................... 510
Ov3 ................................... 510
Ov4 ................................... 510
Caprine ......L......V..............V...... 510
Bovine ............N...................... 512
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Fig. 1. TRIM5α amino acid sequences from ruminants. A) Alignment of TRIM5α amino acid sequences from
ovine (Ov1 to Ov4), caprine and bovine species. Ov1 and Ov2 were amplified from skin fibroblasts of one seronegative
Rasa Aragonesa breed sheep. Ov3 and Ov4 were amplified from bronchoalveolar lavage cDNA from a seropositive 
Rasa Aragonesa sheep RING, B-box-2, Coiled-coil and PRY/SPRY domains are shown and the variable segments 
(V1, V2 and V3) of this domain outlined. Amino acid differences between ovine sequences (Ov1 to Ov4), including 
those corresponding to V1 residue 339 among others, are highlighted in grey. Accession numbers are: Ov1-Ov4 
[GenBank: JN835300-JN835303], caprine [GenBank: JQ582845], bovine [GenBank: DQ380509]. B) Structure of the 
ovine TRIM5, full length isoform (top) and an alternatively spliced form (bottom). 
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Fig. 2. Phylogenetic tree of TRIM nucleotide sequences of different species. The tree shows that all the sheep and goat
TRIM5 sequences described in this work are TRIM5α orthologues. Sequences obtained here had the following GenBank 
accession numbers: JN835300 and JN835301: From Rasa Aragonesa skin fibroblasts. JN835302 and JN835303: From 
Rasa Aragonesa bronchoalveolar lavage. JN835304: From Rasa Aragonesa lung tissue. JN835305: From lung tissue of 
two Rasa Aragonesa and two Assaf sheep. JN835306: From lung tissue of two Assaf and one Churra sheep. 
JN835307: From Assaf lung tissue. JN835308: From Rasa Aragonesa lung tissue. JN835309: From Rasa Aragonesa lung 
tissue. JN835310: From Churra lung tissue. JN835311: From lung tissue of one Assaf and one Churra sheep. 
JQ582845: From peripheral blood mononuclear cells of a Roccaverano goat. JQ582846-48: From peripheral blood 
mononuclear cells of a Murciano-Granadina goat. JQ582849: From peripheral blood mononuclear cells of a 
Murciano-Granadina goat.
